News Search Results

Displaying Results 76-77 of 77 "american academy of dermatology"

May 13, 2025, 16:49 ET Baricitinibe, da Lilly, proporcionou altas taxas de crescimento capilar em adolescentes com alopecia areata grave, aponta estudo

regrowth in adolescents with severe alopecia areata: 36-week efficacy and safety results from a Phase 3 randomized, controlled trial. American Academy of Dermatology Annual Meeting. March 7-11, 20252 Alopecia areata. National Alopecia Areata Foundation

More news about: Eli Lilly do Brasil


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.